DUBLIN–(BUSINESS WIRE)–The “Bioresorbable Stents – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.
Global Bioresorbable Stents Market to Reach $990.5 Million by 2030
The global market for Bioresorbable Stents estimated at US$390.2 Million in the year 2022, is projected to reach a revised size of US$990.5 Million by 2030, growing at a CAGR of 12.4% over the analysis period 2022-2030.
The analysis categorizes bioresorbable stents into polymer-based and metal-based types, examining their sales dynamics. Additionally, it assesses the market’s performance in relation to coronary artery disease (CAD) and peripheral artery disease (PAD) and explores sales trends within healthcare facilities such as hospitals and cardiovascular centers.
Polymer-based, one of the segments analyzed in the report, is projected to record 13.1% CAGR and reach US$729.2 Million by the end of the analysis period. Growth in the Metal-Based segment is estimated at 10.5% CAGR for the next 8-year period.
The report delves into the overall market analysis, covering the period from 2020 to 2030, offering valuable insights for stakeholders in the bioresorbable stents industry. The competitive analysis focuses on competitors like Abbott Laboratories, Boston Scientific Corporation, and Biosensors International Group Ltd.
This report also presents a comprehensive analysis of the global bioresorbable stents market, focusing on Europe, Asia-Pacific, and the Rest of the World regions. It offers insights into the market’s recent past, current status, and future outlook from 2022 to 2030, along with the respective compound annual growth rates (CAGR) in US$ Thousand. The report also provides an 8-year perspective, breaking down the value sales percentages for these regions in 2023 and 2030.
What`s New?
- Special discussions on the global economic climate and market sentiment
- Coverage on global competitiveness and key competitor percentage market shares
- Market presence analysis across multiple geographies – Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and trademarked research platform
- Complimentary updates for one year
- Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 125 |
| Forecast Period | 2022 – 2030 |
| Estimated Market Value (USD) in 2022 | $390.2 Million |
| Forecasted Market Value (USD) by 2030 | $990.5 Million |
| Compound Annual Growth Rate | 12.3% |
| Regions Covered | Global |
MARKET OVERVIEW
- Bioresorbable Stents – Global Key Competitors Percentage Market Share in 2022 (E)
- Coronary Artery Disease (CAD) – A Perspective
- Causes and Symptoms
- Treatment Options for Coronary Artery Disease
- Percutaneous Coronary Intervention (PCI)
- Coronary Stenting
- Types of Coronary Stents
- Bare Metal Stents (BMS)
- Drug Eluting Stents (DES)
- Bioresorbable Scaffolds
- Design and Composition of Bioresorbable Scaffolds
- Different Types of Bioresorbable Scaffolds
- Metallic Bioresorbable Scaffolds
- Polymer Bioresorbable Scaffolds
- Degradation Period of Select Bioabsorbable Materials
- Challenges
- Clinical Characteristics of Various Coronary Stents
- Other Treatment Options for Coronary Heart Disease
- Coronary Artery Bypass Grafting (CABG)
- Minimally Invasive Direct Coronary Artery Bypass (MIDCAB)
- TransMyocardial Laser Revascularization (TMR)
- Peripheral Arterial Disease: Understanding the Stealthy Peril
- Treatment for PAD
- Stenting- A Treatment Option for PAD
- BioResorbable Stents – A Prelude
- Bioresorbable Vascular Scaffolds: Advantages and Challenges
- Bioresorbable Stents – A Revolutionary Technology, Riddled with Controversies
- Abbott Stops Sales of the Once Promising ‘Absorb’ Bioresorbable Stents due to Adverse Events
- Impact of Abbott’s Withdrawal of Absorb on the Bioresorbable Stent Industry
- Impact of Covid-19 and a Looming Global Recession
- 2020 Marked as a Year of Disruption & Transformation
- World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
- Impact of COVID – 19 on Coronary Stents Market
- Impact on Supply Chain
- Impact of COVID-19 Outbreak on Elective Surgeries
- Global Bioresorbable Stents Market Buckles under COVID-19 Strain
- GLOBAL MARKET OVERVIEW
- Global Bioresorbable Stents Set to Witness Growth in Future
- Europe Dominates, Asia-Pacific Exhibits Fastest Growth
- CAD Constitutes the Leading Application
- Metallic Vs. Polymer-based Stents
- Bioabsorbable Metallic Stents
- Bioabsorbable Polymer Stents
- Disappointing Results by Absorb to Increase Focus on Metallic Stents
- Availability of Alternative Treatments – Hindrance to Market Growth
- Market Challenges
- MARKET OUTLOOK
- Bioresorbable and Integrated Biosensor Technology to Redefine Future of Vascular Stents
- The Future of BRS Technology
- COMPETITION
- Select Approved Bioresorbable Scaffolds
- Select Bioresorbable Stents in Pipeline
- Abbott Revives Bioresorbable Stent Clinical Trials to Evaluate New Esprit Scaffold
- Recent Market Activity
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
MARKET TRENDS & DRIVERS
- Polymeric Resorbable Scaffolds Hold a Major Market Share
- The Absorb BRS program
- Desaminotyrosine Polycarbonate-based BRS
- The FANTOM program
- Magnesium-based BRS
- The Magmaris program
- Iron-based BRS
- Global Menace of Coronary Artery Disease (CAD) – A Major Growth Driver
- Global Annual Medical Cost of CVD in the United States: 2015-2030
- Fatalities by Heart Conditions – Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
- Ageing Demographics and Longer Life Expectancy Bolsters Market Growth
- Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
- Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
- Rising Middle Class Population Aids Growth
- Global Middle Class Population (in Millions) by Geographic Region: 2010, 2020P & 2030P
- Rising Healthcare Expenditure: Opportunities in Store
- World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
- Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
- Risk of CAD in Obesity Offers Prospects for Coronary Stenting
- Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
- Diabetics at Higher Risk of Heart Diseases
- TABLE 15: Diabetes Prevalence Worldwide by Region: Number of Adults (20-79 Years) with Diabetes in 2015 and 2040
- The Hypertension-Cholesterol Link to Drive Demand
- Hypertension Prevalence (%) Worldwide by Region in Male and Females Aged 25+ Years
- Metal Bioresorbable scaffolds Exhibit Improved Performance Compared to Polymer Stents
- Metal Stents Vis-a-Vis Other Stents
FOCUS ON SELECT PLAYERS (Total 25 Featured)
- Abbott Laboratories, Inc.
- Boston Scientific Corporation
- Biotronik SE & Co. KG
- Eurocor GmbH
- Biosensors International Group Ltd.
- Elixir Medical Corporation
- InSitu Technologies, Inc.
- Kyoto Medical Planning Co., Ltd.
- Medinol Ltd.
- Lepu Medical Technology (Beijing) Co., Ltd.
- Alvimedica Saglik Ekipmanlari Pazarlama Satis ve Dagitim A.S.
- Meril Life Sciences Pvt., Ltd.
- Arterial Remodeling Technologies SA
- iVascular S.L.U
- Endocor GmbH
For more information about this report visit https://www.researchandmarkets.com/r/zbd1rl
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
